Literature DB >> 30112426

Measuring CD38 Hydrolase and Cyclase Activities: 1,N6-Ethenonicotinamide Adenine Dinucleotide (ε-NAD) and Nicotinamide Guanine Dinucleotide (NGD) Fluorescence-based Methods.

Guilherme C de Oliveira1, Karina S Kanamori1, Maria Auxiliadora-Martins2, Claudia C S Chini1, Eduardo N Chini1.   

Abstract

CD38 is a multifunctional enzyme involved in calcium signaling and Nicotinamide Adenine Dinucleotide (NAD+) metabolism. Through its major activity, the hydrolysis of NAD+, CD38 helps maintain the appropriate levels of this molecule for all NAD+-dependent metabolic processes to occur. Due to current advances and studies relating NAD+ decline and the development of multiple age-related conditions and diseases, CD38 gained importance in both basic science and clinical settings. The discovery and development of strategies to modulate its function and, possibly, treat diseases and improve health span put CD38 under the spotlights. Therefore, a consistent and reliable method to measure its activity and explore its use in medicine is required. We describe here the methods how our group measures both the hydrolase and cyclase activity of CD38, utilizing a fluorescence-based enzymatic assay performed in a plate reader using 1,N6-Ethenonicotinamide Adenine Dinucleotide (ε-NAD) and Nicotinamide Guanine Dinucleotide (NGD) as substrates, respectively.

Entities:  

Keywords:  Aging; CD38; Cyclase; Hydrolase; NAD+; NADase; NGD; ε-NAD

Year:  2018        PMID: 30112426      PMCID: PMC6089541          DOI: 10.21769/BioProtoc.2938

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  13 in total

1.  Regulation of intracellular levels of NAD: a novel role for CD38.

Authors:  Pinar Aksoy; Thomas A White; Michael Thompson; Eduardo N Chini
Journal:  Biochem Biophys Res Commun       Date:  2006-05-15       Impact factor: 3.575

2.  CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues.

Authors:  Eduardo N Chini; Claudia C S Chini; Ichiro Kato; Shin Takasawa; Hiroshi Okamoto
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

4.  Nicotinate-adenine dinucleotide phosphate-induced Ca(2+)-release does not behave as a Ca(2+)-induced Ca(2+)-release system.

Authors:  E N Chini; T P Dousa
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 5.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38.

Authors:  K Kontani; H Nishina; Y Ohoka; K Takahashi; T Katada
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

Review 7.  Cyclic ADP-ribose, the ADP-ribosyl cyclase pathway and calcium signalling.

Authors:  A Galione
Journal:  Mol Cell Endocrinol       Date:  1994-01       Impact factor: 4.102

8.  Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.

Authors:  R M Graeff; T F Walseth; K Fryxell; W D Branton; H C Lee
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

9.  Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.

Authors:  Qun Liu; Richard Graeff; Irina A Kriksunov; Hong Jiang; Bo Zhang; Norman Oppenheimer; Hening Lin; Barry V L Potter; Hon Cheung Lee; Quan Hao
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

10.  Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.

Authors:  Hassina Massudi; Ross Grant; Nady Braidy; Jade Guest; Bruce Farnsworth; Gilles J Guillemin
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  4 in total

1.  NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.

Authors:  Tom Meyer; Dor Shimon; Sawsan Youssef; Gal Yankovitz; Adi Tessler; Tom Chernobylsky; Anat Gaoni-Yogev; Rita Perelroizen; Noga Budick-Harmelin; Lawrence Steinman; Lior Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

2.  Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias.

Authors:  Guillermo Agorrody; Thais R Peclat; Gonzalo Peluso; Luis A Gonano; Leonardo Santos; Wim van Schooten; Claudia C S Chini; Carlos Escande; Eduardo N Chini; Paola Contreras
Journal:  J Mol Cell Cardiol       Date:  2022-02-01       Impact factor: 5.763

3.  TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.

Authors:  Harshad S Ugamraj; Kevin Dang; Laure-Hélène Ouisse; Benjamin Buelow; Eduardo N Chini; Giulia Castello; James Allison; Starlynn C Clarke; Laura M Davison; Roland Buelow; Rong Deng; Suhasini Iyer; Ute Schellenberger; Sankar N Manika; Shipra Bijpuria; Astrid Musnier; Anne Poupon; Maria Cristina Cuturi; Wim van Schooten; Pranjali Dalvi
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

4.  A Novel NAD-RNA Decapping Pathway Discovered by Synthetic Light-Up NAD-RNAs.

Authors:  Florian Abele; Katharina Höfer; Patrick Bernhard; Julia Grawenhoff; Maximilian Seidel; André Krause; Sara Kopf; Martin Schröter; Andres Jäschke
Journal:  Biomolecules       Date:  2020-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.